drugset / Trial / NCT03735849
Evaluating the Safety and Pharmacokinetics of VRC07-523LS in the Sera and Mucosae of Healthy, HIV-Uninfected Adult Participants
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the safety and pharmacokinetics of a human monoclonal antibody (VRC07-523LS) in the sera and mucosae of healthy, HIV-uninfected adults.
Timeline
- Start
- 2019-01-18
- Primary completion
- 2020-12-21
- Completion
- 2020-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VRC07-523LS | Monoclonal antibody | 10 mg/kg | Intravenous |
| Subject | VRC07-523LS | Monoclonal antibody | 30 mg/kg | Intravenous |